Cardiol Therapeutics (CRDL.TO) Q3 2025 Earnings

19AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.19
-0.16
-0.13
-0.1

Details

Expected EPS
-0.1249494829245
Actual EPS
-0.10184577
Surprise EPS
0.02
Surprise Percent
+18.49%

Description

Cardiol Therapeutics (CRDL.TO) has reported earnings of -0.10184577 per share for Q3 2025.

0 Comments

Share your thoughts